Fig. 4From: Early prediction of treatment outcome for lenvatinib using 18F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma refractory to radioiodine treatment: a prospective, multicentre, non-randomised studyROC curve for SUVmax (a) and TLG (b). The AUC for the SUVmax and TLG were 0.714 and 0.643, respectively. FDG PET/CT was performed after 1 week of lenvatinib treatmentBack to article page